1. Home
  2. NTST vs SRPT Comparison

NTST vs SRPT Comparison

Compare NTST & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$21.50

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$15.02

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
SRPT
Founded
2019
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
NTST
SRPT
Price
$21.50
$15.02
Analyst Decision
Strong Buy
Hold
Analyst Count
14
29
Target Price
$22.02
$25.85
AVG Volume (30 Days)
1.4M
3.0M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
4.28%
N/A
EPS Growth
150.00
N/A
EPS
0.12
2.88
Revenue
$195,006,000.00
$2,198,237,000.00
Revenue This Year
$19.03
N/A
Revenue Next Year
$16.25
N/A
P/E Ratio
$179.75
$5.42
Revenue Growth
19.79
15.58
52 Week Low
$17.02
$14.68
52 Week High
$22.47
$25.32

Technical Indicators

Market Signals
Indicator
NTST
SRPT
Relative Strength Index (RSI) 50.69 32.80
Support Level $21.15 N/A
Resistance Level $22.26 $18.16
Average True Range (ATR) 0.54 0.80
MACD -0.08 -0.24
Stochastic Oscillator 28.79 1.16

Price Performance

Historical Comparison
NTST
SRPT

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: